Molecular forms of atrial natriuretic factor in normal and failing human myocardium.
- 1 August 1993
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 88 (2) , 364-371
- https://doi.org/10.1161/01.cir.88.2.364
Abstract
BACKGROUND Atrial natriuretic factor (ANF) is produced by myocardial tissue, and the plasma ANF concentration is known to be elevated in congestive heart failure (CHF). Data from animal models indicate that myocardial concentrations of ANF are depleted in CHF, and this has given rise to the hypothesis that CHF is characterized by depletion of stored ANF. To date, the molecular forms of ANF and their concentrations in atrial and ventricular myocardium remain poorly characterized in the normal and the failing human heart. METHODS AND RESULTS We measured ANF concentrations in fresh tissue from failing human hearts explanted at the time of cardiac transplantation and from organ donors whose normal hearts could not be used for transplantation. We determined total ANF and alpha, beta, and gamma ANF concentrations in the right and left atrial appendages, atrial free walls, and ventricles. In normal hearts, ANF concentration in the atrial appendages was 40-fold higher than ANF in the rest of the atrial free wall and in the ventricles. In the failing hearts, atrial appendage ANF concentrations increased 5- to 10-fold, and atrial free wall ANF concentrations increased 200-fold. Analysis of molecular forms of ANF demonstrated significant increases in the gamma and beta forms in the left atrial appendage of failing hearts. alpha, beta, and gamma ANF forms were also significantly increased in right and left atrial free wall tissue from failing hearts. In addition, failing hearts were characterized by absolute and relative increases in the precursor form gamma ANF. CONCLUSIONS These data from fresh tissues suggest that cardiac ANF stores are not decreased in severe CHF in humans; rather, chronic CHF is characterized by marked increases in atrial ANF tissue concentrations, particularly the beta and gamma ANF forms. These findings are consistent with intracellular accumulation of precursor ANF forms in severe chronic human CHF.Keywords
This publication has 38 references indexed in Scilit:
- Changes of molecular forms of atrial natriuretic peptide after treatment for congestive heart failureJournal of Molecular Medicine, 1988
- Effects of intravenously administered beta-human atrial natriuretic polypeptide in humans.Hypertension, 1988
- Augmented synthesis of β-human atrial natriuretic polypeptide in human failing heartsBiochemical and Biophysical Research Communications, 1988
- Amino acid sequence of atrial natriuretic peptides in human coronary sinus plasmaBiochemical and Biophysical Research Communications, 1987
- Identification of a peptidase which processes atrial natriuretic factor precursor to its active form with 28 amino acid residues in particulate fractions of rat atrial homogenateBiochemical and Biophysical Research Communications, 1987
- Synthesis and presence of atrial natriuretic factor in rat ventricleBiochemical and Biophysical Research Communications, 1986
- Atrial Natriuretic Peptide and Atrial Pressure in Patients with Congestive Heart FailureNew England Journal of Medicine, 1986
- Atriopeptin: A Cardiac Hormone Intimately Involved in Fluid, Electrolyte, and Blood-Pressure HomeostasisNew England Journal of Medicine, 1986
- Changes in the content of atrial natriuretic factor with the progression of hypertension in spontaneously hypertensive ratsBiochemical and Biophysical Research Communications, 1985
- A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in ratsLife Sciences, 1981